On August 4, 2023, the Chinese Medical Association Diabetes Branch 2023 Education Management Academic Conference was grandly held at Fengda International Hotel, Hefei City, Anhui Province. Many experts, scholars and front -line workers from the national diabetic education management field have all attended the meeting. The guests have a good job to actively learn new technologies and clinical progress in the field of diabetes education management after the epidemic.

Mr. Wang Zhongliang, the chairman of Huibang Bio, was sitting in the front row as a spokesman for the dialogue column of the conference. A total of four parts of the dialogue section discuss the hierarchical management and innovative practice of diabetes:

1. "Structure" and "building" in classification management, dialogue chief guest: Professor Zhu Dalong;

2. The "integration" and "through" of the integration practice, the chief guest of the dialogue: Professor Guo Lixin;

3 The "division" and "combined" of digital construction, the chief guest of the dialogue: Professor Guo Xiaoyi;

4. The "sieve" and "defense" in comprehensive prevention and control, the chief guest of the dialogue: Professor Zhang Qiu, dialogue guest: Professor Xing Qiuling Professor Xing Qiuling, Professor Zhang Yongliang, Chairman Wang Zhongliang (Huibang Bio)

When the "sieve" and "defense" in the comprehensive prevention and control of diabetes, Professor Zhang Qiu first introduced the current status of the treatment of diabetes. Although new diabetic therapy drugs have entered the clinic, the complete cure rate of diabetes has not improved significantly. The clinician needs to think about the early screening methods of diabetes and its complications. Finding early screening methods is a new way to improve the treatment effect of diabetes and its complications.

Professor Sun Zilin of Zhongda Hospital affiliated to Nanjing Southeast Medical University in Jiangsu is one of the active advocates of diabetes and its complications. High -risk groups must do a good job of "two screens and three defenses" of diabetes, namely: screen diabetes, screening, screening, screening Check chronic complications; prevent diabetes, prevent complications, prevent the progress of complications, and reduce disability. Diabetes is not terrible. The terrible thing is the complications of diabetes. Two sieves and three precautions, plus a reasonable diet and exercise, can reduce the complications.

Chairman Wang Zhongliang delivered a passionate speech. From 1982, Professor Viberti first proposed the concept of urine micro protein and began to be used in clinical practice. It opened the road of diabetic and nephropathy for more than 40 years, but urine microin white protein, creatinine, and kidney small The sensitivity and specificity of the ball filtration rate have no obvious advantages. Kidney pathological examination (kidney puncture) is more traumatic, which is not conducive to early diagnosis, and is not recommended for conventional use. In 2020, Huibang Bio has launched a diabetic nephropathy non -invasive detection system worldwide.

As early as 2009, Mr. Wang Zhongliang launched the scientific research of urine -binding pearl protein, and began to use the method of electrical and PCR to do genetic types. Because the effect was not ideal, the immune type was used, the effect was very good, and the results of the antibody were stable. HP1-1, HP2-2, and HP2-1 are related to the susceptibility of diabetes. They have certain advantages in the early diagnosis and prognosis prediction of diabetic nephropathy. At the same time, HP is a PDR specific mark. As a result, urine -binding pendial protein/urine trace white protein/creatinine combined test (HP, MALB, CR, ACR, HCR) for early screening for diabetic nephropathy. Huibang Bio applied for six invention patents of chemical light, biochemical, and quantum dot platforms. The manufacturing of inspection instruments combined with biochemical and immune methods, and it was also exclusive to the world.

Applying the binding peedin in urine to clinical clinical, the sensitivity needs to be increased to 106, from the milligram level to the Nak level. At present, the detection of urine -binding pearl protein has been recognized and supported by many experts at home and abroad. Huibang Bio expects cooperation with more experts to achieve non -invasive early screening of diabetic nephropathy at an early date to save the country's cost of chronic diseases and improve the quality of life for patients. In the future, Huibang Bio will continue to pay attention to the development of chronic diseases, take the original path of originality, and continuously launch Chinese manufacturing for the world's chronic disease diagnosis and treatment.